Ai-created virus administered to human for the first time

A patient recently received an AI-designed phage as part of a treatment, marking the first time such a therapy has been used in a human. Radical Numerics, an AI bioscience startup, announced the development of the phage, called Omnii-1, which targets a specific bacterial infection. The treatment is part of phage therapy, an experimental approach that uses viruses to kill bacteria without harming human cells. Radical Numerics claims the AI model designed the phage to combat the patient's infection, though the trial is ongoing and details remain undisclosed. The company, however, has faced criticism for not publishing its findings in a peer-reviewed journal. Instead, Radical Numerics posted its report on its website. CEO Eric Nguyen explained that confidentiality agreements prevent the release of more information, and the team plans to share details once the patient gives consent. Doctors will monitor the patient for months to ensure the infection is fully resolved. Matt Binder, a tech journalist at Mashable, reported on the development, highlighting the significance of the event in the field of AI-driven medical treatments.